Smooth muscle cell-specific Hif-1α deficiency suppresses angiotensin II-induced vascular remodelling in mice

Cardiovascular Research

Volumn 102, Issue 3, 2014, Pages 460-468

  Imanishi, Masaki ^a   Tomita, Shuhei ^a,b   Ishizawa, Keisuke ^a   Kihira, Yoshitaka ^a   Ueno, Masaki ^c   Izawa Ishizawa, Yuki ^a   Ikeda, Yasumasa ^a   Yamano, Noriko ^a   Tsuchiya, Koichiro ^a   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Hypoxia inducible factor 1 (HIF 1); Vascular remodelling; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN II; CD48 ANTIGEN; COLLAGEN TYPE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE P60; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; HIF1A PROTEIN, MOUSE;

ANIMAL EXPERIMENT; AORTA WALL; ARTICLE; BODY WEIGHT; CELL VOLUME; CONTROLLED STUDY; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; HEART HYPERTROPHY; HEART WEIGHT; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SEX DIFFERENCE; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE FIBER SPECIFIC HYPOXIA INDUCIBLE FACTOR 1ALPHA DEFICIENCY; UPREGULATION; ANIMAL; DEFICIENCY; FIBROSIS; GENE EXPRESSION REGULATION; HEMODYNAMICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; FIBROSIS; GENE EXPRESSION REGULATION; HEMODYNAMICS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; SUPEROXIDES; VASCULAR REMODELING;

EID: 84901457818     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu061     Document Type: Article

References (26)

1. Suzuki H, Motley ED, Frank GD, Utsunomiya H, Eguchi S. Recent progress in signal transduction research of the angiotensin II type-1 receptor: Protein kinases, vascular dysfunction and structural requirement. Curr Med Chem Cardiovasc Hematol Agents 2005;3: 305-322.
2. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000;52: 639-672.
3. Sahar S, Reddy MA, Wong C, Meng L, Wang M, Natarajan R. Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2007;27: 1528-1534.
4. Chen XL, Tummala PE, OlbrychMT, AlexanderRW, Medford RM. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 1998;83: 952-959.
5. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 2000;91: 21-27.
6. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998;82: 1298-1305.
7. Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro Keller A, Haymann JP, Baud L. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Circ Res 2008;102: 720-728.
8. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3: 721-732.
9. Lambert CM, Roy M, Meloche J, Robitaille GA, Agharazii M, Richard DE, Bonnet S. Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases. Am J Physiol Heart Circ Physiol 2010;299: H995-1001.
10. Lauzier MC, Page EL, Michaud MD, Richard DE. Differential regulation of hypoxiainducible factor-1 through receptor tyrosine kinase transactivation in vascular smooth muscle cells. Endocrinology 2007;148: 4023-4031.
11. Page EL, Chan DA, Giaccia AJ, Levine M, Richard DE. Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: Role of oxidation and intracellular ascorbate depletion. Mol Biol Cell 2008;19: 86-94.
12. Mylonis I, Chachami G, Samiotaki M, Panayotou G, Paraskeva E, Kalousi A, Georgatsou E, Bonanou S, Simos G. Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha. J Biol Chem 2006;281: 33095-33106.
13. Sato H, Sato M, Kanai H, Uchiyama T, Iso T, Ohyama Y, Sakamoto H, Tamura J, Nagai R, Kurabayashi M. Mitochondrial reactive oxygen species and c-Src play a critical role in hypoxic response in vascular smooth muscle cells. Cardiovasc Res 2005;67: 714-722.
14. Zhao Q, Ishibashi M, Hiasa K, Tan C, Takeshita A, Egashira K. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension 2004;44: 264-270.
15. Tomita S, Ueno M, Sakamoto M, Kitahama Y, Ueki M, Maekawa N, Sakamoto H, Gassmann M, Kageyama R, Ueda N, Gonzalez FJ, Takahama Y. Defective brain development in mice lacking the Hif-1alpha gene in neural cells. Mol Cell Biol 2003;23: 6739-6749.
16. Ikeda Y, Aihara K, Yoshida S, Sato T, Yagi S, Iwase T, Sumitomo Y, Ise T, Ishikawa K, Azuma H, Akaike M, Kato S, Matsumoto T. Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling. Endocrinology 2009;150: 2857-2864.
17. Tajima S, Ikeda Y, Sawada K, Yamano N, Horinouchi Y, Kihira Y, Ishizawa K, Izawa-Ishizawa Y, Kawazoe K, Tomita S, Minakuchi K, Tsuchiya K, Tamaki T. Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. Am J Physiol Endocrinol Metab 2012;302: E77-E86.
18. Yagi S, Akaike M, Aihara K, Ishikawa K, Iwase T, Ikeda Y, Soeki T, Yoshida S, Sumitomo-UedaY, MatsumotoT, Sata M. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury. Hypertension 2010;55: 918-923.
19. Sakurada T, Ishizawa K, Imanishi M, Izawa-Ishizawa Y, Fujii S, Tominaga E, Tsuneishi T, Horinouchi Y, Kihira Y, Ikeda Y, Tomita S, Aihara K, Minakuchi K, Tsuchiya K, Tamaki T. Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects. Naunyn Schmiedebergs Arch Pharmacol 2013;386: 29-39.
20. Matsuura H, Ichiki T, Ikeda J, Takeda K, Miyazaki R, Hashimoto T, Narabayashi E, Kitamoto S, Tokunou T, Sunagawa K. Inhibition of prolyl hydroxylase domain-containing protein downregulates vascular angiotensin II type 1 receptor. Hypertension 2011;58: 386-393.
21. Luther JM, Luo P, Wang Z, Cohen SE, Kim HS, Fogo AB, Brown NJ. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney Int 2012;82: 643-651.
22. Huang Y, Di Lorenzo A, Jiang W, Cantalupo A, Sessa WC, Giordano FJ. Hypoxiainducible factor-1alpha in vascularsmooth muscle regulates blood pressure homeostasis through a peroxisome proliferator-activated receptor-gamma- angiotensin II receptor type 1 axis. Hypertension 2013;62: 634-640.
23. Zhu Q, Wang Z, Xia M, Li PL, Van Tassell BW, Abbate A, Dhaduk R, Li N. Silencing of hypoxia-inducible factor-1alpha gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension 2011;58: 657-664.
24. Foster GE, Hanly PJ, Ahmed SB, Beaudin AE, Pialoux V, Poulin MJ. Intermittent hypoxia increases arterial blood pressure in humans through a Renin-Angiotensin systemdependent mechanism. Hypertension 2010;56: 369-377.
25. Prabhakar NR, Semenza GL. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev 2012;92: 967-1003.
26. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, Cleutjens JP, van den Akker LH, Corvol P, Wouters BG, Daemen MJ, Bijnens AP. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol 2008; 51: 1258-1265.